Marshall Wace, LLP Medpace Holdings, Inc. Transaction History

Marshall Wace, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $734,964 - $1.07 Million	-2,580 Reduced 3.8%	65,253 $26.4 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $5.44 Million - $7.47 Million	-23,889 Reduced 26.05%	67,833 $20.8 Million
Q3 2023 Nov 14, 2023	SELL	$233.98 - $281.67 $14.2 Million - $17.1 Million	-60,599 Reduced 39.78%	91,722 $22.2 Million
Q2 2023 Aug 14, 2023	BUY	$187.26 - $240.17 $28.5 Million - $36.6 Million	152,321 New	152,321 $36.6 Million
Q4 2022 Feb 14, 2023	BUY	$153.06 - $226.57 $1.12 Million - $1.65 Million	7,300 New	7,300 $1.55 Million
Q1 2020 May 15, 2020	SELL	$61.71 - $101.95 $456,345 - $753,920	-7,395 Closed	0 $0
Q4 2019 Feb 14, 2020	SELL	$70.08 - $84.64 $6.83 Million - $8.24 Million	-97,392 Reduced 92.94%	7,395 $621,000
Q3 2019 Nov 14, 2019	SELL	$62.38 - $85.89 $5.61 Million - $7.73 Million	-89,950 Reduced 46.19%	104,787 $8.81 Million
Q2 2019 Aug 14, 2019	BUY	$53.64 - $65.42 $10.4 Million - $12.6 Million	193,060 Added 11512.22%	194,737 $12.7 Million
Q1 2019 May 14, 2019	BUY	$49.38 - $70.58 $82,810 - $118,362	1,677 New	1,677 $99,000
Q2 2018 Aug 14, 2018	SELL	$34.03 - $45.46 $435,584 - $581,888	-12,800 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$32.03 - $39.05 $409,984 - $499,839	12,800 New	12,800 $447,000

617

25.1M

42.8K

207K

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.8B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.